Pharma investment projects
Since 2021 a total of 7 pharma projects were active in Europe, of which 2 are new construction, and 5 expansion projects. Merck, WACKER AG, SEQUENS, Nouryon, and Lonza are the companies involved in het largest number of these projects. Visit the substances page to find out more about substances being targeted in these projects.
With a PIPS Complete subscription you get access to more data and advanced search and reporting tools.